High-Grade Epstein-Barr Virus-Negative Biphenotypic Lymphoma with Expression of B- and T-Cell Markers and Leukemia Presentation: Case Report and Literature Review.

Bigenotypic lymphoma Biphenotypic lymphoma CD3-positive B-cell lymphoma Epstein-Barr virus-negative lymphoma High-grade lymphoma Lymphoma

Journal

Case reports in oncology
ISSN: 1662-6575
Titre abrégé: Case Rep Oncol
Pays: Switzerland
ID NLM: 101517601

Informations de publication

Date de publication:
Historique:
received: 20 07 2020
accepted: 21 07 2020
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 12 11 2020
Statut: epublish

Résumé

Lymphomas are presently categorized according to their origin from B or T lymphocytes. The co-expression of CD3 in B-cell lymphomas or CD20 in T-cell lymphomas has been rarely reported. Immature and less often mature lymphomas may incorporate the rearrangements of both B- and T-cell antigen receptor genes (dual genotype or bigenotype). Lymphoma cells with a sole genotype hardly concurrently express both B- and T-cell markers (biphenotypic lymphomas). We describe a 63-year-old female who was presented with obstructive jaundice and epigastric pain of 10 days. Initial CBC revealed 43×10

Identifiants

pubmed: 33173488
doi: 10.1159/000510403
pii: cro-0013-1215
pmc: PMC7590753
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1215-1226

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors declare that they have no relevant financial interests.

Références

PLoS One. 2015 Sep 01;10(9):e0134833
pubmed: 26325507
Mod Pathol. 2000 Feb;13(2):193-207
pubmed: 10697278
Clin Lymphoma Myeloma. 2009 Apr;9(2):133-7
pubmed: 19406723
Am J Surg Pathol. 2002 Jun;26(6):724-32
pubmed: 12023576
Blood Res. 2013 Jun;48(2):156-60
pubmed: 23826590
J Pathol. 2002 Oct;198(2):171-80
pubmed: 12237876
Am J Surg Pathol. 2009 Apr;33(4):505-12
pubmed: 19011566
Pathology. 2011 Jan;43(1):54-7
pubmed: 21240066
Am J Surg Pathol. 2012 Sep;36(9):1364-70
pubmed: 22895269
Ann Hematol. 2016 Oct;95(10):1671-83
pubmed: 27431583
Annu Rev Immunol. 1988;6:629-62
pubmed: 3289580
PLoS One. 2015 Aug 20;10(8):e0136086
pubmed: 26291626
Am J Hematol. 2004 Oct;77(2):156-60
pubmed: 15389907
Haematologica. 1997 Jan-Feb;82(1):64-6
pubmed: 9107085
Eur J Haematol. 2007 Aug;79(2):159-65
pubmed: 17635241
Leukemia. 2007 Feb;21(2):207-14
pubmed: 17170731
Nature. 2007 Sep 27;449(7161):473-7
pubmed: 17851532

Auteurs

Samah Kohla (S)

Department of Lab Medicine and Pathology, Hematology Division, Hamad Medical Corporation, Doha, Qatar.
Department of Clinical Pathology, Hematology Division, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Feryal A Ibrahim (FA)

Department of Lab Medicine and Pathology, Hematology Division, Hamad Medical Corporation, Doha, Qatar.

Deena Mudawi (D)

Department of Hematology-Oncology, Hamad Medical Corporation, Doha, Qatar.

Susanna Akiki (S)

Department of Lab Medicine and Pathology, Molecular and Cytogenetic Division, Hamad Medical Corporation, Doha, Qatar.

Dina Soliman (D)

Department of Lab Medicine and Pathology, Hematology Division, Hamad Medical Corporation, Doha, Qatar.

Ahmad Al-Sabbagh (A)

Department of Lab Medicine and Pathology, Hematology Division, Hamad Medical Corporation, Doha, Qatar.

Reda R H Youssef (RRH)

Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar.

Mohamed A Yassin (MA)

Department of Hematology-Oncology, Hamad Medical Corporation, Doha, Qatar.

Classifications MeSH